150 related articles for article (PubMed ID: 38224447)
21. Regulation Mechanisms of Virulence Genes in Enterohemorrhagic
Gelalcha BD; Brown SM; Crocker HE; Agga GE; Kerro Dego O
Foodborne Pathog Dis; 2022 Sep; 19(9):598-612. PubMed ID: 35921067
[TBL] [Abstract][Full Text] [Related]
22. A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli O157:H7.
Lissner R; Schmidit H; Karch H
Infection; 1996; 24(5):378-83. PubMed ID: 8923050
[TBL] [Abstract][Full Text] [Related]
23. Identification of genetic markers for differentiation of Shiga toxin-producing, enteropathogenic, and avirulent strains of Escherichia coli O26.
Bugarel M; Beutin L; Scheutz F; Loukiadis E; Fach P
Appl Environ Microbiol; 2011 Apr; 77(7):2275-81. PubMed ID: 21317253
[TBL] [Abstract][Full Text] [Related]
24. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
[TBL] [Abstract][Full Text] [Related]
26. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.
Detzner J; Pohlentz G; Müthing J
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512916
[TBL] [Abstract][Full Text] [Related]
27. Genetics, Toxicity, and Distribution of Enterohemorrhagic
Schwidder M; Heinisch L; Schmidt H
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31470552
[TBL] [Abstract][Full Text] [Related]
28. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.
Thévenot J; Cordonnier C; Rougeron A; Le Goff O; Nguyen HT; Denis S; Alric M; Livrelli V; Blanquet-Diot S
Appl Microbiol Biotechnol; 2015 Nov; 99(21):9097-110. PubMed ID: 26084888
[TBL] [Abstract][Full Text] [Related]
29. Detection of Shiga toxin-producing Escherichia coli by sandwich enzyme-linked immunosorbent assay using chicken egg yolk IgY antibodies.
Parma YR; Chacana PA; Lucchesi PM; Rogé A; Granobles Velandia CV; Krüger A; Parma AE; Fernández-Miyakawa ME
Front Cell Infect Microbiol; 2012; 2():84. PubMed ID: 22919675
[TBL] [Abstract][Full Text] [Related]
30. Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans.
Orth D; Grif K; Zimmerhackl LB; Würzner R
Expert Rev Anti Infect Ther; 2008 Feb; 6(1):101-8. PubMed ID: 18251667
[TBL] [Abstract][Full Text] [Related]
31. Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children.
Cordovéz A; Prado V; Maggi L; Cordero J; Martinez J; Misraji A; Rios R; Soza G; Ojeda A; Levine MM
J Clin Microbiol; 1992 Aug; 30(8):2153-7. PubMed ID: 1500525
[TBL] [Abstract][Full Text] [Related]
32. Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options.
Cointe A; Birgy A; Bridier-Nahmias A; Mariani-Kurkdjian P; Walewski V; Lévy C; Cohen R; Fach P; Delannoy S; Bidet P; Bonacorsi S
J Antimicrob Chemother; 2020 Mar; 75(3):537-542. PubMed ID: 31773130
[TBL] [Abstract][Full Text] [Related]
33. Preservation of protective capacity of hyperimmune anti-Stx2 bovine colostrum against enterohemorrhagic Escherichia coli O157:H7 pathogenicity after pasteurization and spray-drying processes.
Garimano N; Diaz Vergara LI; Kim AD; Badin EE; Sodero S; Bernal AM; Gonzalez DD; Amaral MM; Lespinard AR; Porporatto C; Montenegro MA; Palermo MS; Larzabal M; Cataldi AA; Ibarra C; Sacerdoti F
J Dairy Sci; 2021 May; 104(5):5229-5238. PubMed ID: 33685676
[TBL] [Abstract][Full Text] [Related]
34. Linoleic Acids Overproducing
Peng M; Tabashsum Z; Patel P; Bernhardt C; Biswas D
Front Microbiol; 2018; 9():2663. PubMed ID: 30443248
[TBL] [Abstract][Full Text] [Related]
35. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
[TBL] [Abstract][Full Text] [Related]
36. Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium.
Aldick T; Bielaszewska M; Zhang W; Brockmeyer J; Schmidt H; Friedrich AW; Kim KS; Schmidt MA; Karch H
Microbes Infect; 2007 Mar; 9(3):282-90. PubMed ID: 17314059
[TBL] [Abstract][Full Text] [Related]
37. Production of egg yolk antibody (IgY) against shiga-like toxin (stx) and evaluation of its prophylaxis potency in mice.
Fathi J; Ebrahimi F; Nazarian S; Hajizade A; Malekzadegan Y; Abdi A
Microb Pathog; 2020 Aug; 145():104199. PubMed ID: 32320733
[TBL] [Abstract][Full Text] [Related]
38. Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.
Zhu C; Yu J; Yang Z; Davis K; Rios H; Wang B; Glenn G; Boedeker EC
Clin Vaccine Immunol; 2008 Feb; 15(2):359-66. PubMed ID: 18003816
[TBL] [Abstract][Full Text] [Related]
39. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
[TBL] [Abstract][Full Text] [Related]
40. Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.
Toval F; Schiller R; Meisen I; Putze J; Kouzel IU; Zhang W; Karch H; Bielaszewska M; Mormann M; Müthing J; Dobrindt U
Infect Immun; 2014 Nov; 82(11):4631-42. PubMed ID: 25156739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
